Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 445 to 455 of 455 entries
Sorted by: Best Match Show Resources per page
Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results.

Neuro-oncology

Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, Li Y, Lee EQ, Beroukhim R, Rinne M, McFaline-Figueroa R, Chukwueke U, McCluskey C, Gaffey S, Cherniack AD, Stefanik J, Doherty L, Taubert C, Cifrino M, LaFrankie D, Graillon T, Wen PY, Ligon KL, Al-Mefty O, Huang RY, Muzikansky A, Chiocca EA, Santagata S, Dunn IF, Reardon DA.
PMID: 34015129
Neuro Oncol. 2022 Jan 05;24(1):101-113. doi: 10.1093/neuonc/noab118.

BACKGROUND: Programmed death ligand 1 (PD-L1) contributes to tumor immunosuppression and is upregulated in aggressive meningiomas. We performed a phase II study of nivolumab, a programmed death 1 (PD-1) blocking antibody among patients with grade ≥2 meningioma that recurred...

Cite
Bi WL, Nayak L, Meredith DM, et al. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022;24(1):101-113doi: 10.1093/neuonc/noab118.
Bi, W. L., Nayak, L., Meredith, D. M., Driver, J., Du, Z., Hoffman, S., Li, Y., Lee, E. Q., Beroukhim, R., Rinne, M., McFaline-Figueroa, R., Chukwueke, U., McCluskey, C., Gaffey, S., Cherniack, A. D., Stefanik, J., Doherty, L., Taubert, C., Cifrino, M., LaFrankie, D., Graillon, T., Wen, P. Y., Ligon, K. L., Al-Mefty, O., Huang, R. Y., Muzikansky, A., Chiocca, E. A., Santagata, S., Dunn, I. F., & Reardon, D. A. (2022). Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro-oncology, 24(1), 101-113. https://doi.org/10.1093/neuonc/noab118
Bi, Wenya Linda, et al. "Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results." Neuro-oncology vol. 24,1 (2022): 101-113. doi: https://doi.org/10.1093/neuonc/noab118
Bi WL, Nayak L, Meredith DM, Driver J, Du Z, Hoffman S, Li Y, Lee EQ, Beroukhim R, Rinne M, McFaline-Figueroa R, Chukwueke U, McCluskey C, Gaffey S, Cherniack AD, Stefanik J, Doherty L, Taubert C, Cifrino M, LaFrankie D, Graillon T, Wen PY, Ligon KL, Al-Mefty O, Huang RY, Muzikansky A, Chiocca EA, Santagata S, Dunn IF, Reardon DA. Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results. Neuro Oncol. 2022 Jan 05;24(1):101-113. doi: 10.1093/neuonc/noab118. PMID: 34015129; PMCID: PMC8730772.
Copy Download .nbib Format: NLM
Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements.

Frontiers in neuroscience

Neuville RS, Petrucci MN, Wilkins KB, Anderson RW, Hoffman SL, Parker JE, Velisar A, Bronte-Stewart HM.
PMID: 34858125
Front Neurosci. 2021 Nov 11;15:733203. doi: 10.3389/fnins.2021.733203. eCollection 2021.

No abstract available.

Cite
Neuville RS, Petrucci MN, Wilkins KB, et al. Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements. Front Neurosci. 2021;15:733203doi: 10.3389/fnins.2021.733203.
Neuville, R. S., Petrucci, M. N., Wilkins, K. B., Anderson, R. W., Hoffman, S. L., Parker, J. E., Velisar, A., & Bronte-Stewart, H. M. (2021). Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements. Frontiers in neuroscience, 15733203. https://doi.org/10.3389/fnins.2021.733203
Neuville, Raumin S, et al. "Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements." Frontiers in neuroscience vol. 15 (2021): 733203. doi: https://doi.org/10.3389/fnins.2021.733203
Neuville RS, Petrucci MN, Wilkins KB, Anderson RW, Hoffman SL, Parker JE, Velisar A, Bronte-Stewart HM. Differential Effects of Pathological Beta Burst Dynamics Between Parkinson's Disease Phenotypes Across Different Movements. Front Neurosci. 2021 Nov 11;15:733203. doi: 10.3389/fnins.2021.733203. eCollection 2021. PMID: 34858125; PMCID: PMC8631908.
Copy Download .nbib Format: NLM
Predicting Future PTSD using a Modified New York Risk Score: Implications for Patient Screening and Management.

Minerva psichiatrica

Boscarino JA, Kirchner HL, Hoffman SN, Sartorius J, Adams RE, Figley CR.
PMID: 22408285
Minerva Psichiatr. 2012 Mar;53(1):47-59.

AIM: We previously developed a posttraumatic stress disorder (PTSD) screening instrument - the New York PTSD Risk Score - that was effective in predicting PTSD. In the present study, we assessed a 12-month prospective version of this risk score,...

Cite
Boscarino JA, Kirchner HL, Hoffman SN, et al. Predicting Future PTSD using a Modified New York Risk Score: Implications for Patient Screening and Management. Minerva Psichiatr. 2012;53(1):47-59
Boscarino, J. A., Kirchner, H. L., Hoffman, S. N., Sartorius, J., Adams, R. E., & Figley, C. R. (2012). Predicting Future PTSD using a Modified New York Risk Score: Implications for Patient Screening and Management. Minerva psichiatrica, 53(1), 47-59.
Boscarino, Joseph A, et al. "Predicting Future PTSD using a Modified New York Risk Score: Implications for Patient Screening and Management." Minerva psichiatrica vol. 53,1 (2012): 47-59.
Boscarino JA, Kirchner HL, Hoffman SN, Sartorius J, Adams RE, Figley CR. Predicting Future PTSD using a Modified New York Risk Score: Implications for Patient Screening and Management. Minerva Psichiatr. 2012 Mar;53(1):47-59. PMID: 22408285; PMCID: PMC3298362.
Copy Download .nbib Format: NLM
Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.

PloS one

Zhang Y, Van Laer AO, Baicu CF, Neff LS, Hoffman S, Katz MR, Zeigler SM, Zile MR, Bradshaw AD.
PMID: 35015787
PLoS One. 2022 Jan 11;17(1):e0262479. doi: 10.1371/journal.pone.0262479. eCollection 2022.

Heart failure is a leading cause of hospitalizations and mortality worldwide. Heart failure with a preserved ejection fraction (HFpEF) represents a significant clinical challenge due to the lack of available treatment modalities for patients diagnosed with HFpEF. One symptom...

Cite
Zhang Y, Van Laer AO, Baicu CF, et al. Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF. PLoS One. 2022;17(1):e0262479doi: 10.1371/journal.pone.0262479.
Zhang, Y., Van Laer, A. O., Baicu, C. F., Neff, L. S., Hoffman, S., Katz, M. R., Zeigler, S. M., Zile, M. R., & Bradshaw, A. D. (2022). Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF. PloS one, 17(1), e0262479. https://doi.org/10.1371/journal.pone.0262479
Zhang, Yuhua, et al. "Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF." PloS one vol. 17,1 (2022): e0262479. doi: https://doi.org/10.1371/journal.pone.0262479
Zhang Y, Van Laer AO, Baicu CF, Neff LS, Hoffman S, Katz MR, Zeigler SM, Zile MR, Bradshaw AD. Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF. PLoS One. 2022 Jan 11;17(1):e0262479. doi: 10.1371/journal.pone.0262479. eCollection 2022. PMID: 35015787.
Copy Download .nbib Format: NLM
Replacement of Sodium Tripolyphosphate with Iota Carrageenan in the Formulation of Restructured Ostrich Ham.

Foods (Basel, Switzerland)

Schutte S, Marais J, Muller M, Hoffman LC.
PMID: 33807500
Foods. 2021 Mar 05;10(3). doi: 10.3390/foods10030535.

The influence of iota carrageenan (iota-CGN) as a partial replacement of sodium tripolyphosphate (STPP) was investigated on the physical (pH, yield, instrumental color, texture profile analysis), chemical (moisture, protein, total fat, ash, phosphate) and sensory (descriptive analysis, acceptance testing)...

Cite
Schutte S, Marais J, Muller M, et al. Replacement of Sodium Tripolyphosphate with Iota Carrageenan in the Formulation of Restructured Ostrich Ham. Foods. 2021;10(3)doi: 10.3390/foods10030535.
Schutte, S., Marais, J., Muller, M., & Hoffman, L. C. (2021). Replacement of Sodium Tripolyphosphate with Iota Carrageenan in the Formulation of Restructured Ostrich Ham. Foods (Basel, Switzerland), 10(3), . https://doi.org/10.3390/foods10030535
Schutte, Sumari, et al. "Replacement of Sodium Tripolyphosphate with Iota Carrageenan in the Formulation of Restructured Ostrich Ham." Foods (Basel, Switzerland) vol. 10,3 (2021). doi: https://doi.org/10.3390/foods10030535
Schutte S, Marais J, Muller M, Hoffman LC. Replacement of Sodium Tripolyphosphate with Iota Carrageenan in the Formulation of Restructured Ostrich Ham. Foods. 2021 Mar 05;10(3). doi: 10.3390/foods10030535. PMID: 33807500; PMCID: PMC8000494.
Copy Download .nbib Format: NLM
A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study).

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, Juloori A, Melotek JM, Murgu S, Partouche J, Vokes EE, Weichselbaum RR, Pitroda SP, Patel JD, Chmura SJ.
PMID: 34500113
J Thorac Oncol. 2021 Sep 06; doi: 10.1016/j.jtho.2021.08.019. Epub 2021 Sep 06.

INTRODUCTION: Prior studies have examined stereotactic body radiotherapy (SBRT) in oligometastatic NSCLC patients, including multimodality treatment with anti-PD1 monotherapy. Questions remain regarding the timing of SBRT and immunotherapy, safety with dual checkpoint blockade, and the utility in widely metastatic...

Cite
Bestvina CM, Pointer KB, Karrison T, et al. A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study). J Thorac Oncol. 2021;doi: 10.1016/j.jtho.2021.08.019.
Bestvina, C. M., Pointer, K. B., Karrison, T., Al-Hallaq, H., Hoffman, P. C., Jelinek, M. J., Juloori, A., Melotek, J. M., Murgu, S., Partouche, J., Vokes, E. E., Weichselbaum, R. R., Pitroda, S. P., Patel, J. D., & Chmura, S. J. (2021). A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study). Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, . https://doi.org/10.1016/j.jtho.2021.08.019
Bestvina, Christine M, et al. "A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study)." Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. (2021). doi: https://doi.org/10.1016/j.jtho.2021.08.019
Bestvina CM, Pointer KB, Karrison T, Al-Hallaq H, Hoffman PC, Jelinek MJ, Juloori A, Melotek JM, Murgu S, Partouche J, Vokes EE, Weichselbaum RR, Pitroda SP, Patel JD, Chmura SJ. A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study). J Thorac Oncol. 2021 Sep 06; doi: 10.1016/j.jtho.2021.08.019. Epub 2021 Sep 06. PMID: 34500113.
Copy Download .nbib Format: NLM
A Molecularly Integrated Grade for Meningioma.

Neuro-oncology

Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, Aizer AA, Alexander BM, Ligon KL, Reardon DA, Wen PY, Al-Mefty O, Ligon AH, Dubuc AM, Beroukhim R, Claus EB, Dunn IF, Santagata S, Bi WL.
PMID: 34508644
Neuro Oncol. 2021 Sep 11; doi: 10.1093/neuonc/noab213. Epub 2021 Sep 11.

BACKGROUND: Meningiomas are the most common primary intracranial tumor in adults. Clinical care is currently guided by the World Health Organization (WHO) grade assigned to meningiomas, a three-tiered grading system based on histopathology features, as well as extent of...

Cite
Driver J, Hoffman SE, Tavakol S, et al. A Molecularly Integrated Grade for Meningioma. Neuro Oncol. 2021;doi: 10.1093/neuonc/noab213.
Driver, J., Hoffman, S. E., Tavakol, S., Woodward, E., Maury, E. A., Bhave, V., Greenwald, N. F., Nassiri, F., Aldape, K., Zadeh, G., Choudhury, A., Vasudevan, H. N., Magill, S. T., Raleigh, D. R., Abedalthagafi, M., Aizer, A. A., Alexander, B. M., Ligon, K. L., Reardon, D. A., Wen, P. Y., Al-Mefty, O., Ligon, A. H., Dubuc, A. M., Beroukhim, R., Claus, E. B., Dunn, I. F., Santagata, S., & Bi, W. L. (2021). A Molecularly Integrated Grade for Meningioma. Neuro-oncology, . https://doi.org/10.1093/neuonc/noab213
Driver, Joseph, et al. "A Molecularly Integrated Grade for Meningioma." Neuro-oncology vol. (2021). doi: https://doi.org/10.1093/neuonc/noab213
Driver J, Hoffman SE, Tavakol S, Woodward E, Maury EA, Bhave V, Greenwald NF, Nassiri F, Aldape K, Zadeh G, Choudhury A, Vasudevan HN, Magill ST, Raleigh DR, Abedalthagafi M, Aizer AA, Alexander BM, Ligon KL, Reardon DA, Wen PY, Al-Mefty O, Ligon AH, Dubuc AM, Beroukhim R, Claus EB, Dunn IF, Santagata S, Bi WL. A Molecularly Integrated Grade for Meningioma. Neuro Oncol. 2021 Sep 11; doi: 10.1093/neuonc/noab213. Epub 2021 Sep 11. PMID: 34508644.
Copy Download .nbib Format: NLM
Psychological well-being and alcohol misuse among community-based veterans: results from the Veterans' Health Study.

Journal of addictive diseases

Adams RE, Boscarino JA, Hoffman SN, Urosevich TG, Kirchner HL, Boscarino JJ, Dugan RJ, Withey CA, Figley CR.
PMID: 34521314
J Addict Dis. 2021 Sep 14;1-10. doi: 10.1080/10550887.2021.1972747. Epub 2021 Sep 14.

BACKGROUND: Maladaptive drinking is an increasing concern among military policy makers and healthcare providers. The goal of this study was to assess how social and psychological factors relate to alcohol problems among post-deployed US veterans and how problematic drinking...

Cite
Adams RE, Boscarino JA, Hoffman SN, et al. Psychological well-being and alcohol misuse among community-based veterans: results from the Veterans' Health Study. J Addict Dis. 2021;1-10doi: 10.1080/10550887.2021.1972747.
Adams, R. E., Boscarino, J. A., Hoffman, S. N., Urosevich, T. G., Kirchner, H. L., Boscarino, J. J., Dugan, R. J., Withey, C. A., & Figley, C. R. (2021). Psychological well-being and alcohol misuse among community-based veterans: results from the Veterans' Health Study. Journal of addictive diseases, 1-10. https://doi.org/10.1080/10550887.2021.1972747
Adams, Richard E, et al. "Psychological well-being and alcohol misuse among community-based veterans: results from the Veterans' Health Study." Journal of addictive diseases vol. (2021): 1-10. doi: https://doi.org/10.1080/10550887.2021.1972747
Adams RE, Boscarino JA, Hoffman SN, Urosevich TG, Kirchner HL, Boscarino JJ, Dugan RJ, Withey CA, Figley CR. Psychological well-being and alcohol misuse among community-based veterans: results from the Veterans' Health Study. J Addict Dis. 2021 Sep 14;1-10. doi: 10.1080/10550887.2021.1972747. Epub 2021 Sep 14. PMID: 34521314.
Copy Download .nbib Format: NLM
[Swollen fingers and curved nails].

La Revue de medecine interne

Hoffman C, Amrane S, Bagneres D, Granel B.
PMID: 34607729
Rev Med Interne. 2021 Nov;42(11):816-819. doi: 10.1016/j.revmed.2021.08.017. Epub 2021 Oct 01.

No abstract available.

Cite
Hoffman C, Amrane S, Bagneres D, et al. Des doigts gonflés et des ongles recourbés. [Swollen fingers and curved nails]. Rev Med Interne. 2021;42(11):816-819doi: 10.1016/j.revmed.2021.08.017.
Hoffman, C., Amrane, S., Bagneres, D., & Granel, B. (2021). Des doigts gonflés et des ongles recourbés. [Swollen fingers and curved nails]. La Revue de medecine interne, 42(11), 816-819. https://doi.org/10.1016/j.revmed.2021.08.017
Hoffman, C, et al. "Des doigts gonflés et des ongles recourbés." [Swollen fingers and curved nails]. La Revue de medecine interne vol. 42,11 (2021): 816-819. doi: https://doi.org/10.1016/j.revmed.2021.08.017
Hoffman C, Amrane S, Bagneres D, Granel B. Des doigts gonflés et des ongles recourbés. [Swollen fingers and curved nails]. Rev Med Interne. 2021 Nov;42(11):816-819. doi: 10.1016/j.revmed.2021.08.017. Epub 2021 Oct 01. French. PMID: 34607729.
Copy Download .nbib Format: NLM
Parental mental health screening in the NICU: a psychosocial team initiative.

Journal of perinatology : official journal of the California Perinatal Association

Grunberg VA, Geller PA, Hoffman C, Njoroge W, Ahmed A, Patterson CA.
PMID: 34580422
J Perinatol. 2021 Sep 27; doi: 10.1038/s41372-021-01217-0. Epub 2021 Sep 27.

OBJECTIVE: About 40-50% of parents with children admitted to Neonatal Intensive Care Units (NICU) experience clinically significant levels of depression, anxiety, and trauma. Poor parental mental health can negatively influence parent-child interactions and child development. Therefore, early identification of...

Cite
Grunberg VA, Geller PA, Hoffman C, et al. Parental mental health screening in the NICU: a psychosocial team initiative. J Perinatol. 2021;doi: 10.1038/s41372-021-01217-0.
Grunberg, V. A., Geller, P. A., Hoffman, C., Njoroge, W., Ahmed, A., & Patterson, C. A. (2021). Parental mental health screening in the NICU: a psychosocial team initiative. Journal of perinatology : official journal of the California Perinatal Association, . https://doi.org/10.1038/s41372-021-01217-0
Grunberg, Victoria A, et al. "Parental mental health screening in the NICU: a psychosocial team initiative." Journal of perinatology : official journal of the California Perinatal Association vol. (2021). doi: https://doi.org/10.1038/s41372-021-01217-0
Grunberg VA, Geller PA, Hoffman C, Njoroge W, Ahmed A, Patterson CA. Parental mental health screening in the NICU: a psychosocial team initiative. J Perinatol. 2021 Sep 27; doi: 10.1038/s41372-021-01217-0. Epub 2021 Sep 27. PMID: 34580422.
Copy Download .nbib Format: NLM
A Global Pandemic Treaty Must Address Antimicrobial Resistance.

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics

Wilson LA, Van Katwyk SR, Weldon I, Hoffman SJ.
PMID: 35006051
J Law Med Ethics. 2021;49(4):688-691. doi: 10.1017/jme.2021.94.

Antimicrobial resistance (AMR) is one of the defining global health threats of our time, but no international legal instrument currently offers the framework and mechanisms needed to address it. Fortunately, the actions needed to address AMR have considerable overlap...

Cite
Wilson LA, Van Katwyk SR, Weldon I, et al. A Global Pandemic Treaty Must Address Antimicrobial Resistance. J Law Med Ethics. 2021;49(4):688-691doi: 10.1017/jme.2021.94.
Wilson, L. A., Van Katwyk, S. R., Weldon, I., & Hoffman, S. J. (2021). A Global Pandemic Treaty Must Address Antimicrobial Resistance. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 49(4), 688-691. https://doi.org/10.1017/jme.2021.94
Wilson, Lindsay A, et al. "A Global Pandemic Treaty Must Address Antimicrobial Resistance." The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics vol. 49,4 (2021): 688-691. doi: https://doi.org/10.1017/jme.2021.94
Wilson LA, Van Katwyk SR, Weldon I, Hoffman SJ. A Global Pandemic Treaty Must Address Antimicrobial Resistance. J Law Med Ethics. 2021;49(4):688-691. doi: 10.1017/jme.2021.94. PMID: 35006051.
Copy Download .nbib Format: NLM
Showing 445 to 455 of 455 entries